Literature DB >> 24169407

The role of aquaporin-1 in idiopathic and drug-induced intracranial hypertension.

H Stiebel-Kalish1, S Eyal, I Steiner.   

Abstract

Idiopathic intracranial hypertension is a common disorder affecting mainly healthy, young, overweight women. The pathogenesis of this condition is unknown, but it has been shown to follow treatment with several compounds including corticosteroids and vitamin A derivatives. This paper will offer a novel hypothesis and insight on the pathogenesis of drug induced intracranial hypertension following a review and analysis of the literature. Both corticosteroids and vitamin A derivatives have been shown to upregulate the expression of aquaporin 1, a water channel protein. Aquaporin 1 is widely distributed in the human brain and is associated with water secretion into the subarachnoid space. Aquaporin 1 was also shown to participate in the regulation of weight. Agents used for treating idiopathic intracranial hypertension reduce aquaporin 1 expression. Based on these observations, we propose that aquaporin 1 has a pathogenetic role in drug induced idiopathic intracranial hypertension. Over expression of this gene causes increased intracranial pressure, and downregulation reduces pressure and alleviates the symptomatology and complications of idiopathic intracranial hypertension.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AQP1; AQPs; CSF; ICP; IIH; PTC; RAR; RAREs; RXR; aquaporin 1; aquaporins; cerebrospinal fluid; idiopathic intracranial hypertension; intracranial pressure; pseudotumor cerebri; retinoic acid receptor; retinoic acid response elements; retinoid X receptor

Mesh:

Substances:

Year:  2013        PMID: 24169407     DOI: 10.1016/j.mehy.2013.10.002

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  4 in total

Review 1.  Current concepts and strategies in the diagnosis and management of idiopathic intracranial hypertension in adults.

Authors:  Jane W Chan
Journal:  J Neurol       Date:  2017-01-31       Impact factor: 4.849

2.  Role of vitamin A metabolism in IIH: Results from the idiopathic intracranial hypertension treatment trial.

Authors:  J Libien; M J Kupersmith; W Blaner; M P McDermott; S Gao; Y Liu; J Corbett; M Wall
Journal:  J Neurol Sci       Date:  2016-11-10       Impact factor: 3.181

3.  Choroid plexus aquaporin 1 and intracranial pressure are increased in obese rats: towards an idiopathic intracranial hypertension model?

Authors:  M Uldall; D K Bhatt; C Kruuse; M Juhler; I Jansen-Olesen; R H Jensen
Journal:  Int J Obes (Lond)       Date:  2017-03-27       Impact factor: 5.095

4.  Familial non-obese idiopathic intracranial hypertension.

Authors:  Raed Behbehani; Abdullah Ali; Ashref J Al-Mousa; Sarah N Albuloushi
Journal:  Am J Ophthalmol Case Rep       Date:  2022-06-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.